Spotlight on risankizumab and its potential in the treatment of plaque psoriasis: evidence to date
Álvaro Machado,1 Tiago Torres1,2 1Department of Dermatology, Centro Hospitalar Universitário do Porto, Porto, Portugal; 2Instituto de Ciências Biomédicas Abel Salazar, University of Porto, Porto, Portugal Abstract: Psoriasis is a common chronic immune-mediated skin disease, with systemic involvement...
Saved in:
Main Authors: | Machado Á (Author), Torres T (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2018-11-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Spotlight on brodalumab in the treatment of plaque psoriasis: the evidence to date
by: Galluzzo M, et al.
Published: (2019) -
Spotlight on blisibimod and its potential in the treatment of systemic lupus erythematosus: evidence to date
by: Lenert A, et al.
Published: (2017) -
Spotlight on ertugliflozin and its potential in the treatment of type 2 diabetes: evidence to date
by: Cinti F, et al.
Published: (2017) -
Spotlight on siponimod and its potential in the treatment of secondary progressive multiple sclerosis: the evidence to date
by: Gajofatto A
Published: (2017) -
Clinical Evaluation of Risankizumab-rzaa in the Treatment of Plaque Psoriasis
by: Reddy V, et al.
Published: (2020)